Graduate Departmental Seminars

The Graduate Department of Pharmaceutical Sciences offers an exciting seminar program featuring scientists from across Canada and around the world, with occasional seminars by our own faculty and members of other departments at U of T and surrounding hospitals/institutes. The seminars provide an opportunity for all to meet outstanding, world-renowned scientists. Seminar speakers also schedule additional time for informal discussions with faculty and students. Regular attendance at seminars is required of all graduate students.


Seminar Coordinator

Dr. Rob Macgregor
E-mail: rob.macgregor@utoronto.ca
Telephone: (416) 978-7332

Booking Information

Seemin Qureshi
E-mail: phm.grad@utoronto.ca


Graduate Departmental Seminar Series Requirement

All graduate students are required to attend the departmental seminars each year:

  • Full-time students: a minimum of eight (8) departmental seminars per academic year
  • Part-time/Flex-time students: a minimum of four (4) departmental seminars per academic year.

Students may fulfill up to 50% of their annual quota at sanctioned external seminars.


2019-2020 Graduate Departmental Seminar Series Schedule

(All seminars take place at the Leslie Dan Faculty of Pharmacy, 144 College Street, unless noted.)

 

DATE AND LOCATION SPEAKER AFFILIATION HOST / SUPERVISOR SEMINAR TITLE
Thursday  November 14, 2019 at 12pm, Room PB 1210 Clarke Bhandari Cole World Health Organization’s Collaborating Centre for Governance, Accountability and Transparency in the Pharmaceutical Sector Dr. Jillian Kohler Measuring and incentivising pharmaceutical industry contributions to health R&D
Friday November 15, 2019 at 9:00am, Room PB1210 Camille Alam Exit Seminar – PhD Candidate
Graduate Department of Pharmaceutical Sciences
Dr. Reina Bendayan Regulation of Folate Transport at the Blood-Brain Barrier: A Novel Strategy for the Treatment of Childhood Neurological Disorders Associated with Cerebral Folate Deficiency
Friday November 15, 2019, at 2pm, Room PB 850 Dr. Robert Thorne Denali Fellow, Denali Therapeutics, South San Francisco, California; thorne@dnli.com

Adjunct Associate Professor, Department of Pharmaceutics, University of Minnesota

Vice President, International Brain Barriers Society (IBBS)

Dr. Reina Bendayan “Large molecule drug delivery to the brain: new approaches for neurodegenerative and lysosomal storage diseases guided by engineering and physiology
Thursday November 21, 2019, at 10am, Room PB 1210  Dr. Michael J. Rieder Professor with the Department of Paediatrics, Physiology and Pharmacology and Medicine at Schulich Medicine & Dentistry, Western University Dr. Reina Bendayan Drug Safety in Children – A Moving Target
Thursday November 21, 2019 at 1:00pm, Room PB1210 Amila Omeragic Exit Seminar – PhD Candidate
Graduate Department of Pharmaceutical Sciences
Dr. Reina Bendayan Peroxisome Proliferator-Activated Receptor-gamma (PPARγ) agonists: Potential Novel Treatment for HIV-1 Associated Brain Inflammation
Tuesday December 3, 2019 at 11:00am, Room PB1210 Yi Rang (Nellie) Han Exit Seminar – PhD Candidate
Graduate Department of Pharmaceutical Sciences
Dr. Ping Lee Understanding Critical Parameters Affecting the Dissolution of Amorphous Solid Dispersions
Friday December 13, 2019 at 11am, Room PB 850 Oksana Pyzik Senior Teaching Fellow and Global Engagement Lead, University College London Dr. Zubin Austin TBC
Friday December 13, 2019 at 12:30pm, Room PB850 Tian Zhang Exit Seminar – PhD Candidate
Graduate Department of Pharmaceutical Sciences
Dr. Shirley Wu Integrin-targeted Polymer-lipid Nanoparticles Encapsulating Synergistic Drug Combinations for Therapy of Triple Negative Breast Cancer Metastasis
Monday December 16, 2019 at 2pm, Room PB850 Dr. Singh Professor, Pathology and Molecular Medicine, Molecular Medicine, McMaster Dr. Shirley Wu Role of Endocannabinoids in Pain
Friday February 7, 2020, at 11 am, Room PB 850 Dr. Gennady Poda Scientific Advisor & Group Leader, Computational Chemistry & Chemoinformatics, Drug Discovery Program. Assistant Professor at LDFP. Dr. Carolyn Cummins Using Structure-Based Design and Chemoinformatics Approaches to Accelerate Drug Discovery: Development of Oral Bcl6 and ALK2 Inhibitors for the treatment of Cancers
Friday March 13, 2020, at 11am, Room PB 850 Dr. Gang Han Professor, University of Massachusetts Medical School. Dr. Gang Zheng TBC

 

 


Previous schedules:

2019-2020

2018-2019

2017-2018

2016-2017